Management of patients with metastatic prostate cancer
Intended for healthcare professionals
CPD Previous     Next

Management of patients with metastatic prostate cancer

Bruce Turner Uro-oncology nurse practitioner, Department of Urology, Homerton University Hospital, London
Lawrence Drudge-Coates Uro-oncology clinical nurse specialist and honorary lecturer, King’s College Hospital, London

Prostate cancer is the most common cancer in men and is recognised as a significant health problem. Treatment of advanced or metastatic prostate cancer is challenging, and support and care should be tailored to meet the individual’s needs. This article focuses on the pharmacological management of metastatic prostate cancer and the nurse’s role in providing patients with information about the disease. It is hoped that this article will be used as a resource to improve patient care.

Nursing Standard. 26, 27, 49-57. doi: 10.7748/ns2012.03.26.27.49.c8984

Peer review

This article has been subject to double blind peer review

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more